SOURCE: BBK Worldwide

June 16, 2015 11:09 ET

BBK Worldwide Launches Full-Service Patient Travel Program

Underscoring Its Commitment to Patient Centricity, RSG® Arrive Eases Study Visit Travel Burdens, Expands Research Participation

WASHINGTON, DC and BOSTON, MA--(Marketwired - June 16, 2015) - DIA Annual Meeting -- BBK Worldwide, a leading clinical trial marketing firm, today announced the availability of RSG® Arrive, a full-service concierge program created to more fully support clinical trial patients and operationalize travel for pharmaceutical companies, especially important for rare disease studies where recruitment of patients extends well beyond the area of the site, often in different countries. The latest offering within the company's RSG® Suite of engagement services, RSG Arrive leverages industry best practices to offer streamlined adherence and workflows, all at a reduced cost. The program has been implemented across several global studies, and sponsor and patient feedback has been overwhelmingly positive.

Designed to optimize the millions of dollars spent on study-related care annually and support the demands inherent in today's growing personalized approach to research, RSG Arrive manages all travel-related logistics -- operational and financial -- for trial patients and sites. From car and shuttle booking, to international flight and accommodation management, RSG Arrive ensures that patients get to and from study visits as simply and seamlessly as possible; removing what can be a heavy burden for study patients and the study teams supporting them. RSG Arrive can also provide complementary services for patients requiring additional support, as well as offer sponsors a turn-key solution to streamline retention efforts at the site level.

"With few to no options available to them, those suffering from the most devastating of illnesses are often unable to participate in clinical research because the few highly specialized physician investigators are simply too far away," said Jaime Cohen, strategic consultation and research, BBK Worldwide. "The goal is two-fold -- to ensure that patients participating in clinical trials have the support they need, and to remove what can be a primary and costly -- and ultimately unnecessary -- study enrollment barrier."

Additionally, because the program leverages BBK's cloud-based patient recruitment platform all travel logistics are linked to individual patient and study visits and are updated and available in real-time, providing clarity and saving study teams valuable time, budget and resources -- all within a secure and confidential environment.

Visit BBK booth #2026 at the DIA Annual Meeting to learn more about the company's software solutions and consulting services for improved patient recruitment and engagement. Members of the media and analyst communities interested in meeting with BBK Worldwide at the show can contact Juli Greenwood at 617-515-8412 or jgreenwood@bbkworldwide.com for scheduling.

Follow @BBKWorldwide on Twitter and join the conversation with #DIA2015 and #BBKatDIA.

Additional Resources

About BBK Worldwide
With more than three decades of experience across a wide variety of therapies and medicines, BBK Worldwide is the global leader in patient recruitment and engagement for the clinical trial industry. BBK's innovative software solutions and consulting services leverage the company's adaptive recruitment methodology to protect global enrollment integrity, specifically within an ever-changing or threatened landscape. For more information, visit www.bbkworldwide.com.

Image Available: http://www.marketwire.com/library/MwGo/2015/6/16/11G044966/Images/ARRIVE-APP-FLIP-300dpi-1353921131862.jpg

Contact Information